EMERGING_SOLUTIONS_PRODUC - Accounts


Company registration number 03423411 (England and Wales)
EMERGING SOLUTIONS PRODUCT LINES LIMITED
TRADING AS THERAPY
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
PAGES FOR FILING WITH REGISTRAR
EMERGING SOLUTIONS PRODUCT LINES LIMITED
TRADING AS THERAPY
BALANCE SHEET
AS AT
31 MARCH 2023
31 March 2023
- 1 -
2023
2022
£
£
£
£
Fixed assets
19,075
13,627
Current assets
64,597
82,151
Creditors: amounts falling due within one year
(11,827)
(14,771)
Net current assets
52,770
67,380
Total assets less current liabilities
71,845
81,007
Net assets
71,845
81,007
Capital and reserves
71,845
81,007
Notes to the financial statements
1
Employees

The average number of persons, including directors, employed by the company during the year was as follows:

2023
2022
Number
Number
Employees
6
4

Emerging Solutions Product Lines Limited is a private company limited by shares incorporated in England and Wales. The registered office is 249 Eachelhurst Road, Sutton Coldfield, West Midlands, United Kingdom, B76 1DT.

For the year ended 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

(e) the company has relied on the specified exemption as a micro company contained in section 352 Companies Act 2014; the company has done so on the grounds that it is entitled to the benefit of that exemption as a small company and I confirm that the abridged financial statements have been properly prepared in accordance with section 353 Companies Act 2014.true

EMERGING SOLUTIONS PRODUCT LINES LIMITED
TRADING AS THERAPY
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2023
31 March 2023
- 2 -
The financial statements were approved and signed by the director and authorised for issue on 18 September 2023
Miss E E Smith
Director
Company registration number 03423411 (England and Wales)
2023-03-312022-04-01falseCCH SoftwareCCH Accounts Production 2023.100No description of principal activityMiss E E SmithMiss E E Smith034234112022-04-012023-03-31034234112023-03-31034234112022-03-3103423411core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3103423411core:CurrentFinancialInstrumentscore:WithinOneYear2022-03-31034234112021-04-012022-03-3103423411bus:CompanySecretaryDirector12022-04-012023-03-3103423411bus:PrivateLimitedCompanyLtd2022-04-012023-03-3103423411bus:SmallCompaniesRegimeForAccounts2022-04-012023-03-3103423411bus:Micro-entities2022-04-012023-03-3103423411bus:AuditExemptWithAccountantsReport2022-04-012023-03-3103423411bus:Director12022-04-012023-03-3103423411bus:CompanySecretary12022-04-012023-03-3103423411bus:FullAccounts2022-04-012023-03-31xbrli:purexbrli:sharesiso4217:GBP